Citation: Y. Barak et al., FLUOXETINE TREATMENT OF DEPRESSION IN PATIENTS SUFFERING FROM MULTIPLE-SCLEROSIS, Human psychopharmacology, 13(1), 1998, pp. 66-67
Authors:
POYUROVSKY M
BERGMAN Y
SHOSHANI D
SCHNEIDMAN M
WEIZMAN A
Citation: M. Poyurovsky et al., EMERGENCE OF OBSESSIVE-COMPULSIVE SYMPTOMS AND TICS DURING CLOZAPINE WITHDRAWAL, Clinical neuropharmacology, 21(2), 1998, pp. 97-100
Authors:
TOLLEFSON GD
TRAN PV
BIRKETT M
SHOSHANI D
Citation: Gd. Tollefson et al., TREATMENT FAILURE WITH CLOZAPINE - CAN OLANZAPINE BE THE ALTERNATIVE THERAPY, Schizophrenia research, 24(1-2), 1997, pp. 191-191
Authors:
TRAN P
SHAMIR E
POYOROVSKI M
LOKSHIN P
WEIZER N
DORFMAN P
MARK M
BIRKETT M
BENASSAYAG E
SHOSHANI D
WIMMER P
DOSSENBACH M
Citation: P. Tran et al., OLANZAPINE IN THE TREATMENT OF PATIENTS WHO FAILED TO RESPOND TO OR TOLERATE CLOZAPINE, Psychopharmacology bulletin, 33(3), 1997, pp. 599-599
Authors:
BARAK Y
STEIN D
LEVINE J
RING A
HADJEZ J
ELIZUR A
SHOSHANI D
Citation: Y. Barak et al., THYROXINE AUGMENTATION OF FLUOXETINE TREATMENT FOR RESISTANT DEPRESSION IN THE ELDERLY - AN OPEN TRIAL, Human psychopharmacology, 11(6), 1996, pp. 463-467